BMC Medical Genetics (Dec 2011)

Association analysis identifies <it>ZNF750 </it>regulatory variants in psoriasis

  • Birnbaum Ramon Y,
  • Hayashi Genki,
  • Cohen Idan,
  • Poon Annie,
  • Chen Haoyan,
  • Lam Ernest T,
  • Kwok Pui-Yan,
  • Birk Ohad S,
  • Liao Wilson

DOI
https://doi.org/10.1186/1471-2350-12-167
Journal volume & issue
Vol. 12, no. 1
p. 167

Abstract

Read online

Abstract Background Mutations in the ZNF750 promoter and coding regions have been previously associated with Mendelian forms of psoriasis and psoriasiform dermatitis. ZNF750 encodes a putative zinc finger transcription factor that is highly expressed in keratinocytes and represents a candidate psoriasis gene. Methods We examined whether ZNF750 variants were associated with psoriasis in a large case-control population. We sequenced the promoter and exon regions of ZNF750 in 716 Caucasian psoriasis cases and 397 Caucasian controls. Results We identified a total of 47 variants, including 38 rare variants of which 35 were novel. Association testing identified two ZNF750 haplotypes associated with psoriasis (p ZNF750 promoter and 5' UTR variants displayed a 35-55% reduction of ZNF750 promoter activity, consistent with the promoter activity reduction seen in a Mendelian psoriasis family with a ZNF750 promoter variant. However, the rare promoter and 5' UTR variants identified in this study did not strictly segregate with the psoriasis phenotype within families. Conclusions Two haplotypes of ZNF750 and rare 5' regulatory variants of ZNF750 were found to be associated with psoriasis. These rare 5' regulatory variants, though not causal, might serve as a genetic modifier of psoriasis.